|
121
|
|
|
- |
ROA1 |
|
|
122
|
|
|
OTU deubiquitinase, ubiquitin aldehyde binding 2 |
C14orf137, OTB2, OTU2 |
|
|
123
|
|
|
Olfactory receptor family 7 subfamily E member 94 pseudogene |
- |
|
|
124
|
|
|
Olfactory receptor family 2 subfamily H member 2 |
FAT11, OLFR2, OLFR42B, OR2H3, dJ271M21.2, hs6M1-12 |
|
|
125
|
|
|
Olfactory receptor family 10 subfamily R member 1 pseudogene |
OR1-10 |
|
|
126
|
|
|
Outer mitochondrial membrane lipid metabolism regulator OPA3 |
MGA3 |
|
|
127
|
|
|
Olfactory receptor family 10 subfamily Q member 2 pseudogene |
- |
|
|
128
|
|
|
Olfactory receptor family 5 subfamily V member 1 |
6M1-21, hs6M1-21 |
Alzheimer disease, Anorexia nervosa, Asthma, Attention deficit hyperactivity disorder, Autism, Barrett esophagus, Breast cancer, Interstitial cystitis, Obstructive pulmonary disease, Dental caries, Diabetes mellitus, Diabetic neuropathy, Esophageal adenocarcinoma, Female infertility, Gout, Insomnia, Major depressive disorder, Migraine, Non-hodgkins lymphoma, Non-melanoma skin carcinoma, Psoriasis, Retinopathy, Rheumatoid arthritis, Sarcoidosis, Schizophrenia, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2View all (12 more) |
|
129
|
|
|
Olfactory receptor family 2 subfamily B member 2 |
OR2B2Q, OR2B9, OR6-1, dJ193B12.4, hs6M1-10 |
Alzheimer disease, Obstructive pulmonary disease, Gastroesophageal reflux disease, Human immunodeficiency virus infection, Insomnia, Lung cancer, Major depressive disorder, Kawasaki disease, Neurotic disorder, Peptic ulcer disease, Post-traumatic stress disorder, Squamous Cell Carcinoma, Upper aerodigestive tract neoplasm |
|
130
|
|
|
Olfactory receptor family 12 subfamily D member 3 |
hs6M1-27 |
|
